Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mar Boente-Carrera"'
Autor:
Neal N Padte, Mar Boente-Carrera, Chasity D Andrews, Jenny McManus, Brooke F Grasperge, Agegnehu Gettie, Jordana G Coelho-dos-Reis, Xiangming Li, Douglass Wu, Joseph T Bruder, Martha Sedegah, Noelle Patterson, Thomas L Richie, Chi-Huey Wong, David D Ho, Sandhya Vasan, Moriya Tsuji
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e78407 (2013)
A key strategy to a successful vaccine against malaria is to identify and develop new adjuvants that can enhance T-cell responses and improve protective immunity. Upon co-administration with a rodent malaria vaccine in mice, 7DW8-5, a recently identi
Externí odkaz:
https://doaj.org/article/9f9aeffae151400bbaac60e368566594
Autor:
Sandhya Vasan, Arlene Hurley, Sarah J Schlesinger, Drew Hannaman, David F Gardiner, Daniel P Dugin, Mar Boente-Carrera, Roselle Vittorino, Marina Caskey, Johanne Andersen, Yaoxing Huang, Josephine H Cox, Tony Tarragona-Fiol, Dilbinder K Gill, Hannah Cheeseman, Lorna Clark, Len Dally, Carol Smith, Claudia Schmidt, Harriet H Park, Jakub T Kopycinski, Jill Gilmour, Patricia Fast, Robert Bernard, David D Ho
Publikováno v:
PLoS ONE, Vol 6, Iss 5, p e19252 (2011)
DNA-based vaccines have been safe but weakly immunogenic in humans to date.We sought to determine the safety, tolerability, and immunogenicity of ADVAX, a multigenic HIV-1 DNA vaccine candidate, injected intramuscularly by in vivo electroporation (EP
Externí odkaz:
https://doaj.org/article/54e6c0214ce848db98e3291e78e074a0
Autor:
Sandhya Vasan, Sarah J Schlesinger, Zhiwei Chen, Arlene Hurley, Angela Lombardo, Soe Than, Phumla Adesanya, Catherine Bunce, Mark Boaz, Rosanne Boyle, Eddy Sayeed, Lorna Clark, Daniel Dugin, Mar Boente-Carrera, Claudia Schmidt, Qing Fang, LeiBa, Yaoxing Huang, Gerasimos J Zaharatos, David F Gardiner, Marina Caskey, Laura Seamons, Martin Ho, Len Dally, Carol Smith, Josephine Cox, Dilbinder Gill, Jill Gilmour, Michael C Keefer, Patricia Fast, David D Ho
Publikováno v:
PLoS ONE, Vol 5, Iss 1, p e8816 (2010)
We conducted a Phase I dose-escalation trial of ADMVA, a Clade-B'/C-based HIV-1 candidate vaccine expressing env, gag, pol, nef, and tat in a modified vaccinia Ankara viral vector. Sequences were derived from a prevalent circulating HIV-1 recombinant
Externí odkaz:
https://doaj.org/article/25b6bfc4047d47d09e9a293a9d14fcdd
Autor:
Kristina Rodriguez, Chasity D. Andrews, Martin Markowitz, Hiroshi Mohri, Agegnehu Gettie, Cecilia Cheng-Mayer, David D. Ho, Mar Boente-Carrera, Kasi E. Russell-Lodrigue, Zhi Hong, William Spreen, Leslie St. Bernard, Yun Lan Yueh, James Blanchard, Susan L. Ford
Publikováno v:
Science Translational Medicine. 7
Long-acting GSK1265744 (GSK744 LA) is a strand transfer inhibitor of the HIV/SIV (simian immunodeficiency virus) integrase and was shown to be an effective preexposure prophylaxis (PrEP) agent in a low-dose intrarectal SHIV (simian-human immunodefici
Autor:
Martha Sedegah, Xiangming Li, Brooke Grasperge, Jenny McManus, Chi-Huey Wong, Agegnehu Gettie, David D. Ho, Douglass Wu, Noelle B. Patterson, Neal N. Padte, Moriya Tsuji, Mar Boente-Carrera, Thomas L. Richie, Jordana Grazziela Coelho-dos-Reis, Sandhya Vasan, Chasity D. Andrews, Joseph T. Bruder
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 10, p e78407 (2013)
PLoS ONE, Vol 8, Iss 10, p e78407 (2013)
A key strategy to a successful vaccine against malaria is to identify and develop new adjuvants that can enhance T-cell responses and improve protective immunity. Upon co-administration with a rodent malaria vaccine in mice, 7DW8-5, a recently identi
Autor:
Drew Hannaman, Harriet Park, Mar Boente-Carrera, Patricia E. Fast, Robert M. Bernard, Roselle Vittorino, Lorna Clark, Marina Caskey, David D. Ho, Sarah J. Schlesinger, Jakub Kopycinski, Jill Gilmour, Josephine H. Cox, Carol Smith, David F. Gardiner, Yaoxing Huang, C. Schmidt, Daniel Dugin, Tony Tarragona-Fiol, Johanne Andersen, Dilbinder K. Gill, Arlene Hurley, Hannah Cheeseman, Len Dally, Sandhya Vasan
Publikováno v:
PLoS ONE
PLoS ONE, Vol 6, Iss 5, p e19252 (2011)
PLoS ONE, Vol 6, Iss 5, p e19252 (2011)
Background: DNA-based vaccines have been safe but weakly immunogenic in humans to date. Methods and Findings: We sought to determine the safety, tolerability, and immunogenicity of ADVAX, a multigenic HIV-1 DNA vaccine candidate, injected intramuscul
Autor:
Carol Smith, C. Schmidt, Mar Boente-Carrera, Marina Caskey, Rosanne Boyle, Catherine A. Bunce, Len Dally, David F. Gardiner, Dilbinder K. Gill, Zhiwei Chen, Sandhya Vasan, Qing Fang, Lorna Clark, Mark Boaz, Gerasimos J. Zaharatos, Phumla Adesanya, Daniel Dugin, Angela Lombardo, Martin Ho, Patricia E. Fast, Laura Seamons, Ba Lei, Arlene Hurley, Eddy Sayeed, Yaoxing Huang, Michael C. Keefer, Sarah J. Schlesinger, Josephine H. Cox, David D. Ho, Jill Gilmour, Soe Than
Publikováno v:
PLoS ONE, Vol 5, Iss 1, p e8816 (2010)
PLoS ONE
PLoS ONE
Background We conducted a Phase I dose-escalation trial of ADMVA, a Clade-B'/C-based HIV-1 candidate vaccine expressing env, gag, pol, nef, and tat in a modified vaccinia Ankara viral vector. Sequences were derived from a prevalent circulating HIV-1
Autor:
Patricia E. Fast, Jill Gilmour, David D. Ho, C. Schmidt, J Andersen, Sarah J. Schlesinger, Sandhya Vasan, Marina Caskey, Lorna Clark, Mar Boente-Carrera, Tony Tarragona, Robert M. Bernard, Arlene Hurley, Roselle Vittorino, David F. Gardiner, Carol Smith, Len Dally, Yaoxing Huang, Drew Hannaman, Harriet Park, Daniel Dugin, Eddy Sayeed, Josephine H. Cox, Dilbinder K. Gill, Hannah Cheeseman
Publikováno v:
Retrovirology, Vol 6, Iss Suppl 3, p O31 (2009)
Retrovirology
Retrovirology
Open Access Oral presentation OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers S Vasan*1, A Hurley1, SJ Schlesinger1, D Hannaman2, DF Gardiner1, DP Dugin1, MM Boente-Car